As of April 18, 2025, BioAtla (BCAB) has a market cap of $18.910 million USD. According to our data, BioAtla is ranked No.8580 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $18.91 M |
-44.86%
|
Dec 31, 2024 | $34.29 M |
-75.98%
|
Dec 29, 2023 | $0.14 B |
-70.18%
|
Dec 30, 2022 | $0.48 B |
-57.97%
|
Dec 31, 2021 | $1.14 B |
-42.28%
|
Dec 31, 2020 | $1.97 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.80 B |
-0.000 M
|
![]() Canada
|
![]() ADC Therapeutics
ADCT
|
$0.12 B |
-0.000 M
|
![]() Switzerland
|
![]() Mersana Therapeutics
MRSN
|
$44.21 M |
-0.037 M
|
![]() USA
|
![]() Sutro Biopharma
STRO
|
$43.95 M |
0.385 M
|
![]() USA
|
![]() I-Mab Biopharma
IMAB
|
$68.88 M |
0.016 M
|
![]() China
|
![]() Pieris Pharmaceuticals
PIRS
|
$17.96 M |
0.000 M
|
![]() USA
|
![]() CytomX Therapeutics
CTMX
|
$52.55 M |
0.000 M
|
![]() USA
|
![]() Avidity Biosciences
RNA
|
$3.20 B |
0.000 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.12 B |
-0.670 M
|
![]() USA
|
![]() Xencor
XNCR
|
$0.68 B |
-0.000 M
|
![]() USA
|
![]() AbCellera
ABCL
|
$0.72 B |
0.000 M
|
![]() Canada
|
Market Cap | = | BCAB Stock Price | * | BCAB Shares Outstanding |
= | $0.32 | * | 58.40 M | |
= | $18.91 M |